FibroGen, Inc. (FGEN)
8.38
-0.32
(-3.68%)
USD |
NASDAQ |
Dec 12, 16:00
8.435
+0.06
(+0.66%)
After-Hours: 20:00
FibroGen Research and Development Expense (Quarterly): 1.209M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 0.379M |
| Harrow, Inc. | 3.323M |
| Skye Bioscience, Inc. | 9.178M |
| Theravance Biopharma, Inc. | 7.707M |
| NovaBay Pharmaceuticals, Inc. | -- |